70010-48-9Relevant articles and documents
On the trade-off between processability and opto-electronic properties of single wall carbon nanotube derivatives in thin film heterojunctions
Salice, Patrizio,Sartorio, Camillo,Burlini, Alessandro,Improta, Roberto,Pignataro, Bruno,Menna, Enzo
, p. 303 - 312 (2015)
A flow functionalization route has been employed to derivatize single wall carbon nanotubes (SWCNTs) by thienylphenyl groups. The SWCNT derivatives in the most soluble fraction have been characterized by thermogravimetric analysis, DLS analysis, DFT calculations, and UV-vis-NIR, microRaman and IR spectroscopies to study the degree of functionalization, the concentration of SWCNTs in solution, the dimension of the aggregates in solutions, the density of defects, and the presence of the thienylphenyl groups. Thin-film heterojunctions made of SWCNT derivatives and poly(3-hexylthiophene) (P3HT) have been prepared by various methods employing the Langmuir-Schaefer technique, spin-coating and thermal annealing processes. By comparing the batch and the flow functionalizations, a trade-off between solubility, processability and the thin-film opto-electronic properties has been found as a result of the degree of functionalization.
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
Kitamura, Naoya,Sacco, Michael Dominic,Ma, Chunlong,Hu, Yanmei,Townsend, Julia Alma,Meng, Xiangzhi,Zhang, Fushun,Zhang, Xiujun,Ba, Mandy,Szeto, Tommy,Kukuljac, Adis,Marty, Michael Thomas,Schultz, David,Cherry, Sara,Xiang, Yan,Chen, Yu,Wang, Jun
, (2021/05/29)
The main protease (Mpro) of SARS-CoV-2 is a validated antiviral drug target. Several Mpro inhibitors have been reported with potent enzymatic inhibition and cellular antiviral activity, including GC376, boceprevir, calpain inhibitors II, and XII, with eac
COMPOUNDS AND METHODS TO ATTENUATE TUMOR PROGRESSION AND METASTASIS
-
, (2020/05/28)
This invention relates to certain compounds or pharmaceutically acceptable salts thereof, and for the use of the compounds to treat cancer. In another aspect, the disclosure relates to a pharmaceutical composition comprising a compound of Formula (1), For
Novel substituted benzoyl compound and its pharmaceutically acceptable salt and preparation method and application (by machine translation)
-
, (2019/11/13)
The invention relates to the general formula I shown novel substituted benzoyl compound and its pharmaceutically acceptable salt and preparation method and application. The invention also provides pharmaceutical compositions containing them, in vitro and in vivo anti-tumor effect results and acute toxicity study, the obtained anti-tumor drug model substituted benzoyl compound, has more excellent anti-tumor activity and safety, can be in the treatment of leukemia, lung cancer, colon cancer, ovarian cancer and renal carcinoma tumor in the application, so that the therapeutic window, so in the medical field as antitumor agents in the very application value. (by machine translation)